Article
Immune responses to transgene and retroviral vector in patients treated with ex vivo–engineered T cells
2 Oct 2010
Abstract excerpt
Adoptive transfer of immune effector cells that are gene modified by retroviral transduction to express tumor-specific receptors constitutes an attractive approach to treat cancer. In patients with metastatic renal cell carcinoma, we performed a study with autologous T cells genetically retargeted with a chimeric antibody receptor (CAR) directed toward carbonic anhydrase IX (CAIX), an antigen highly expressed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
